Endotoxin removal by polymyxin B: is it a question of dose or duration or both?

Crit Care. 2019 Sep 4;23(1):297. doi: 10.1186/s13054-019-2584-5.

Authors

Patrick M Honore¹, David De Bels², Leonel Barreto Gutierrez², Sebastien Redant², Andrea Gallerani², Willem Boer³

Affiliations

¹ ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, Brussels, Belgium. [email protected].
² ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, Brussels, Belgium.
³ Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine & Pain Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.

No abstract available

Publication types

Letter
Comment

MeSH terms

Endotoxins
HLA-DR Antigens
Hemoperfusion*
Humans
Polymyxin B
Sepsis*

Substances

Endotoxins
HLA-DR Antigens
Polymyxin B